Prestige Consumer Healthcare
PBH
#3944
Rank
NZ$5.17 B
Marketcap
NZ$105.22
Share price
-0.22%
Change (1 day)
-27.52%
Change (1 year)

Revenue for Prestige Consumer Healthcare (PBH)

Revenue in 2025 (TTM): NZ$1.92 Billion

According to Prestige Consumer Healthcare's latest financial reports the company's current revenue (TTM ) is NZ$1.90 Billion. In 2024 the company made a revenue of NZ$1.98 Billion an increase over the revenue in the year 2023 that were of NZ$1.79 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Prestige Consumer Healthcare from 2005 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$1.92 B-3.16%
2024 NZ$1.98 B10.55%
2023 NZ$1.79 B2.7%
2022 NZ$1.74 B12.79%
2021 NZ$1.54 B16.76%
2020 NZ$1.32 B-6.27%
2019 NZ$1.41 B-4.21%
2018 NZ$1.47 B2.25%
2017 NZ$1.44 B17.82%
2016 NZ$1.22 B6.43%
2015 NZ$1.15 B34.95%
2014 NZ$0.85 B15.22%
2013 NZ$0.74 B1.06%
2012 NZ$0.73 B41.82%
2011 NZ$0.51 B28.02%
2010 NZ$0.40 B-1.05%
2009 NZ$0.40 B-25.99%
2008 NZ$0.55 B30.28%
2007 NZ$0.42 B-7%
2006 NZ$0.45 B5.44%
2005 NZ$0.43 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
GlaxoSmithKline
GSK
NZ$72.78 B 3,713.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$107.89 B 5,553.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
NZ$40.34 B 2,014.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$158.35 B 8,198.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$1.04 B-44.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$96.87 B 4,976.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
NZ$145.95 B 7,548.32%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$677.23 B 35,387.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$11.63 B 509.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$75.34 B 3,848.12%๐Ÿ‡บ๐Ÿ‡ธ USA